Top 10 Feature Articles of 2024

News
Article

The BioPharm International® editors present our most popular technical articles from 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

BioPharm International® publishes independent, science-based articles and peer-reviewed papers from biopharmaceutical professionals working in the development and manufacturing of biologics. In 2024, BioPharm International®, via print issues, ebooks, and our website, BioPharmInternational.com, published articles on topics ranging from cell and gene therapies, viral clearance, fill/finish, aseptic processing, and more.

The following are our picks for the ‘best of’ technical and peer-reviewed articles published in 2024, in no particular order:

For more peer-reviewed articles, please visit https://www.biopharminternational.com/topic/peer-reviewed-research.
For the latest on drug development, please visit https://www.biopharminternational.com/topic/development.
To read in-depth upstream processing articles, visit https://www.biopharminternational.com/topic/upstream.
A variety of quality-related topics can be found at https://www.biopharminternational.com/topic/quality. And the latest manufacturing technologies are discussed at https://www.biopharminternational.com/topic/manufacturing.

For information on how to submit technical and peer-reviewed articles to BioPharm International®, please view our submission guidelines at https://www.biopharminternational.com/view/editorial-information.

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.